Looks Like This Service Is On Hold
I will write a pharma market entry plan for global expansion
Bangladesh
About this Gig
Are you a pharmaceutical company, health-tech startup, or medical brand looking to expand into new markets but unsure where to start, what the regulations are, or whether the opportunity is worth pursuing?
I'm Tasnimur a Pharmaceutical business development professional. Over the past 4+ years I have personally researched, written business cases for, and signed agreements across 20+ countries in Central Asia, Africa, and the Americas. I don't just write about market entry I have done it, repeatedly, for a multinational.
What I deliver:
· Market sizing and opportunity assessment
· Regulatory landscape and product registration requirements
· Competitive landscape and key local players
· Recommended go-to-market strategy and distribution model
· Pricing benchmarks and reimbursement insights
· Risk assessment and mitigation plan
· Full business case or executive-ready proposal
Markets I know best:
Bangladesh, CIS, EAC, Maghreb, French-West Africa, CAM, Carribeans, ASEAN
Why my work is different: I have achieved 87% year-on-year growth across my portfolio and negotiated 15+ distribution agreements personally. Your report won't be generic research it will reflect what actually works.
Business Stage:
Pre-Seed
•
Seed
•
Series A
Language:
Bengali
•
English
Plan format:
PowerPoint presentation
•
Word doc
•
Industry:
Health & Medical
FAQ
Do you cover markets outside your list?
Yes. I have strong research methodology for any emerging or frontier market. Message me first and I'll confirm whether I have direct experience or will rely on deep secondary research, I'll always be transparent.
Is this only for pharmaceutical companies?
No. My core expertise is pharma, but the methodology applies to any regulated health, consumer goods, or B2B product entering a new market. Healthcare devices, nutraceuticals, and FMCG brands are all welcome.
What makes your work more reliable than a regular business writer?
I have signed real distribution agreements and launched products in these markets, not as a consultant, but as the person doing the work. I know what questions regulators ask, what distributors want to see, and what makes or breaks a deal.

